Q2 2017 Holdings
Filed 2017-08-10 | 378 holdings | $47.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Signature Bank(SBNY) | COM | 82669G104 | $16.5K | 114,820 | 0.0% |
| Allergan Plc | COM | G0177J108 | $16.7K | 68,700 | 0.0% |
| U.S. Silica Holdings, Inc.(SLCAUSD) | COM | 90346E103 | $16.8K | 472,400 | 0.0% |
| Facebook, Inc. Class A(META) | COM | 30303M102 | $16.8K | 111,150 | 0.0% |
| Jazz Pharmaceuticals Plc(JAZZ) | COM | G50871105 | $17.0K | 109,120 | 0.0% |
| Broadcom LTD SHS(AVGO) | COM | Y09827109 | $17.0K | 72,930 | 0.0% |
| Celgene Corp.(CELG) | COM | 151020104 | $17.2K | 132,120 | 0.0% |
| Chevron Corp.(CVX) | COM | 166764100 | $17.8K | 170,800 | 0.0% |
| Bank of America Corp.(BAC) | COM | 060505104 | $21.8K | 897,710 | 0.0% |
| Schlumberger Ltd.(SLB) | COM | 806857108 | $21.8K | 331,350 | 0.0% |
| Diamondback Energy, Inc.(FANG) | COM | 25278X109 | $23.3K | 262,701 | 0.0% |
| Exxon Mobil Corp.(XOM) | COM | 30231G102 | $34.4K | 425,500 | 0.1% |
| Charles River Laboratories Int(CRL) | COM | 159864107 | $303.0K | 3,000 | 0.6% |
| Credit Acceptance Corporation(CACC) | COM | 225310101 | $360.0K | 1,400 | 0.8% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $407.0K | 8,700 | 0.9% |
| Ally Financial Inc(ALLY) | COM | 02005N100 | $713.0K | 34,100 | 1.5% |
| Builders FirstSource Inc.(BLDR) | COM | 12008R107 | $1.2M | 76,600 | 2.5% |
| Cirrus Logic Inc.(CRUS) | COM | 172755100 | $1.2M | 19,100 | 2.5% |
| Alibaba Group Holding Ltd. Spo(BABA) | ADR | 01609W102 | $1.3M | 9,200 | 2.7% |
| Crown Holdings Inc.(CCK) | COM | 228368106 | $1.8M | 30,000 | 3.8% |
| Costco Wholesale Corp.(COST) | COM | 22160K105 | $2.3M | 14,500 | 4.9% |
| AutoZone Inc.(AZO) | COM | 053332102 | $2.6M | 4,620 | 5.5% |
| Antero Resources Corporation(AR) | COM | 03674X106 | $4.1M | 190,700 | 8.7% |
| Adobe Systems Inc.(ADBE) | COM | 00724F101 | $4.6M | 32,580 | 9.7% |
| Constellation Brands Inc.(STZ) | COM | 21036P108 | $5.8M | 29,700 | 12.1% |
| AbbVie Inc(ABBV) | COM | 00287Y109 | $5.9M | 80,800 | 12.3% |
| Boston Scientific Corp.(BSX) | COM | 101137107 | $6.8M | 244,600 | 14.2% |
| Cbre Group Inc(CBRE) | COM | 12504L109 | $6.9M | 190,390 | 14.5% |